SEHK:1093
SEHK:1093Pharmaceuticals

How Investors Are Reacting To CSPC Pharmaceutical Group (SEHK:1093) Advancing New Hypertension and Diabetes Treatments

CSPC Pharmaceutical Group recently reported that its aldosterone synthase inhibitor SYH2072 secured U.S. FDA and China NMPA approvals to begin clinical trials for uncontrolled and resistant hypertension, while its fixed-dose Prusogliptin and Metformin Extended-Release diabetes therapy application was accepted by China’s NMPA. These parallel advances in hypertension and type 2 diabetes programs highlight CSPC’s push into higher-value, patent-protected treatments across major chronic disease...
SEHK:2171
SEHK:2171Biotechs

CARsgen Therapeutics Holdings SEHK 2171 Valuation After New Solid Tumor Collaboration With Dispatch Bio

Why this new collaboration matters for CARsgen Therapeutics Holdings (SEHK:2171) CARsgen Therapeutics Holdings (SEHK:2171) just announced a clinical collaboration with Dispatch Bio to run a Phase 1 trial in China, testing a combined approach for treating solid tumors using both companies' immunotherapies. The study, planned to begin in 2026, will evaluate DISP-11, which uses Dispatch's Flare platform and DV-10 tumor specific virus together with CARsgen's zevorcabtagene autoleucel, or zevor...
SEHK:3808
SEHK:3808Machinery

3 Asian Dividend Stocks To Consider With Up To 8.9% Yield

As Asia's markets navigate a complex landscape of regulatory changes and economic shifts, investors are increasingly focused on opportunities that provide stable returns amidst volatility. In this environment, dividend stocks stand out for their potential to deliver consistent income, making them an attractive option for those looking to balance growth prospects with reliable payouts.
SEHK:2252
SEHK:2252Medical Equipment

Asian Market Stocks That May Be Priced Below Intrinsic Value Estimates

As Asian markets navigate a complex landscape of regulatory changes and economic shifts, investors are increasingly focused on identifying stocks that may be priced below their intrinsic value. In this environment, a good stock is often characterized by strong fundamentals and resilience to market fluctuations, making it an attractive option for those seeking potential opportunities in undervalued equities.